Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Intramyocardial Implantation of Allogeneic Mesenchymal Stem Cells in Patients With End-stage Heart Failure Undergoing Left Ventricular Assist Device Implantation

NCT01759212 is registered in ClinicalTrials.gov with AHEPA University Hospital as lead sponsor.

NCT NCT01759212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01759212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Intramyocardial Implantation of Allogeneic Mesenchymal Stem Cells in Patients With End-stage Heart Failure Undergoing Left Ventricular Assist Device Implantation
Lead sponsor
AHEPA University Hospital
Phase
Phase 2/3
Overall status
Terminated
Start date
October 31, 2012
Completion date
July 31, 2022
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, ischemic cardiomyopathy